#Current version
final_base.write.mode('overwrite').option('OverwriteSchema', True).format('delta').save('/mnt/oiadlsrootfnd/Pharma/Local/BZL/Commercial/Sales/Order-Intelligence/DS/DE_Input/DeltaTables/Raw/coin_bzl_base_v4')








MODEL_NAME
DEPLOYMENT_NAME
TOKEN_LIMIT
BRAND
MARKET
REGION
INPUT_TOKEN_LIMIT
OUTPUT_TOKEN_LIMIT
TOKEN_RATE_LIMIT
PROJECT_INPUT_LIMIT
ADDED_BY
ENTRY_TIME


MODEL_NAME : gpt-4o
DEPLOYMENT_NAME	: RxEUAIModelUATFFNGPT-4o
TOKEN_LIMIT	: 2800 
BRAND : SHINGRIX
MARKET : VNM
REGION : APNA	
INPUT_TOKEN_LIMIT	: 120000
OUTPUT_TOKEN_LIMIT : 4000
TOKEN_RATE_LIMIT	: 100000
PROJECT_INPUT_LIMIT	:15000
ADDED_BY	: abc.x.abc@gsk.com
ENTRY_TIME : current_timestamp()


hive_metastore.fieldforce_navigator_deployment.d_ffn_competitor_config

MARKET : THA	
BRAND	: AREXVY
DISEASE_STATE	: RSV vaccine
DRUG_CLASS	: Non-adjuvanted
COMPETITOR_BRANDS	: Abrysvo
COMPETITION_TYPE : COMPETITOR
ADDED_BY	: abc.x.abc@gsk.com
ENTRY_TIME : current_timestamp()	
MOLECULE	: RSVPreF
OTHER_NAMES	: null
COMBINATION : null




hive_metastore.fieldforce_navigator_deployment.d_ffn_insight_config

BRAND
MARKET
INSIGHT
TYPE
VALUE_1
VALUE_2
VALUE_3
VALUE_4
ADDED_BY
ENTRY_TIME


hive_metastore.fieldforce_navigator_deployment.llm_insight_seq_default

INSIGHT_TYPE : overall-area-of-interest-insight
SEQ  : 6
IS_ACTIVE : FALSE
PROMPT_ID : 170
POST_PROCESS : TRUE
ACTIVITY_TYPE : Self
PROCESS_BY_CHUNK : FALSE
PUBLISH_INSIGHT_NAME : OVERALL_AREA_OF_INTEREST_INSIGHT
ENTRY_TIME : current_timestamp()	
ADDED_BY	: abc.x.abc@gsk.com





hive_metastore.fieldforce_navigator_deployment.llm_prompt_input_data_config_default

PROMPT_ID : 197
VARIABLE : transcript
INPUT_TABLE_NAME : llm_audio_processed_outputs
INPUT_COL_NAME : output
INPUT_FILTERS : {"INSIGHT_TYPE": "speaker-assignment"}
TO_BE_CHUNKED : TRUE
INPUT_PROCESSING : input_default
IS_ACTIVE : TRUE
ENTRY_TIME : current_timestamp()	
ADDED_BY	: abc.x.abc@gsk.com




